Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

New England Journal of Medicine

Volumn 334, Issue 4, 1996, Pages 225-230

  Caron, Huib ^a,b   Van Sluis, Peter ^b   De Kraker, Jan ^a   Bökkerink, Jos ^c   Egeler, Maarten ^d   Laureys, Geneviève ^e   Slater, Rosalyn ^b   Westerveld, Andries ^b   Voute P A ^a   Versteeg, Rogier ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELISM; ARTICLE; CANCER MORTALITY; CANCER STAGING; CHILD; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 4P; CONTROLLED STUDY; DISEASE COURSE; FERRITIN BLOOD LEVEL; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

BLOTTING, SOUTHERN; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 1; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; GENE AMPLIFICATION; GENES, MYC; HUMANS; INFANT; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 13344275864     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199601253340404     Document Type: Article

References (24)

1. Voûte PA, de Kraker J, Hoefnagel CA Tumors of the sympathetic nervous system: neuroblastoma, ganglioneuroma and phaeochromocytoma In: Voûte PA, Barrett A, Lemerle J, eds Cancer in children: clinical management. 3rd ed. Berlin, Germany. Springer-Verlag, 1992.
2. Berthold F, Trechow R, Utsch S, Zieschang J. Prognostic factors in metastatic neuroblastoma: a multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 1992;14:207-15.
3. Shuster JJ, McWilliams NB, Castleberry R, et al. Serum lactate dehydrogenase in childhood neuroblastoma: a Pediatric Oncology Group recursive partitioning study. Am J Clin Oncol 1992;15:295-303.
4. Silber JH, Evans AE, Fridman M. Models to predict outcome from childhood neuroblastoma the role of serum ferritin and tumor histology. Cancer Res 1991;51.1426-33
5. Shimada H, Chatten J, Newton WA Jr. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984,73:405-16.
6. Joshi VV, Cantor AB, Altshuler G, et al. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas: a clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer 1992,69 2197-211
7. Fong CT, White PS, Peterson K, et al. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas Cancer Res 1992;52:1780-5.
8. Caron HN, van Sluis P, van Hoeve M, et al. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification Nat Genet 1993;4 187-90. [Erratum. Nat Genet 1993; 4:431.]
9. Takeda O, Homma C, Maseki N, et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosom Cancer 1994;10:30-9
10. Schleiermacher G, Peter M, Michon J, et al. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosom Cancer 1994,10:275-81.
11. Srivatsan ES, Murali V, Seeger RC. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma. Prog Clin Biol Res 1991;366: 91-8
12. Suzuki T, Yokota J, Mugishima H, et al Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 1989;49:1095-8.
13. Schwab M, Alitalo KL, Klempnauer KH, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 1983;305:245-8.
14. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N Engl J Med 1985;313.1111-6.
15. Bourhis J, De Vathaire F, Wilson GD, et al Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma Cancer Res 1991;51:33-6.
16. Van Roy N, Laureys G, Cheng NC, et al 1;17 Translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines Genes Chromosom Cancer 1994;10:103-14
17. Caron HN, van Sluis P, van Roy N, et al. Recurrent 1;17 translocations in human neuroblastomas reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 1994;55:341-7.
18. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma N Engl J Med 1984,311:231-5.
19. Caron HN. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995;24:215-21
20. Ambros PF, Ambros IM, Strehl S, et al. Regression and progression in neuroblastoma, does genetics predict tumor behaviour? Eur J Cancer 1995, 31A:510-6.
21. Evans AE, D'Angio GJ, Randolph J. A proposed staging system for children with neuroblastoma: children's cancer study group A. Cancer 1971;27:374-8
22. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983,31:1333-5.
23. Campos-Filho N, Franco EL Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimators. Comput Methods Programs Biomed 1988;27:223-8.
24. Idem. A microcomputer program for multiple logistic regression by unconditional and conditional maximum likelihood methods. Am J Epidemiol 1989;129 439-44.